EUVIMEDEUVIMED entdecken
Crossref

Exploring TH17-mediated inflammation in epidermolytic ichthyosis: Clinical and mechanistic insight

Yidong Tan, Xuanyi Chen, Yihang Shen, Jinxiang Yang, Bing Wang, Yumeng Wang, Weinan Zhou, Qiuyi Han, Zhirong Yao, Huaguo Li, Jianying Liang

Clinical Immunology · 2025

DOI: 10.1016/j.clim.2025.110494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2025. Verfasst von Yidong Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Dermatology, Shanghai Jiaotong U…. Hauptthemen laut MEDLINE: Th17 Cells, Hyperkeratosis, Epidermolytic, Inflammation. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Fundamental Research Funds for Central Universities of the Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermolytic ichthyosis (EI) is a genetic skin disorder caused by mutations in the KRT1 and KRT10 genes, leading to severe skin abnormalities and inflammation. Current treatment options are limited, emphasizing the need for pathogenesis-based therapies. This study investigates the role of T helper type 17 (TH17) inflammatory responses in EI and explores the mechanisms underlying these responses. We found that patients from the family carrying both KRT1 and MPO mutations exhibited varying degrees of psoriasis-like manifestations and significant therapeutic responses to anti-IL-17 A treatment. The treatment efficacy was also confirmed in patients with KRT10 mutations. Mechanistically, Single-nucleus RNA sequencing revealed significantly elevated levels of TH-17 related cytokines in epidermis and CCR6+ TH17 cell infiltration in the dermis. Additionally, we observed aberrant activation of the IκBα-JNK-c-Jun signaling pathway, leading to heightened IL-8 expression and exacerbated inflammation. Our findings underscore the critical role of TH17-mediated inflammation in the pathogenesis of EI and suggest potential therapeutic avenues targeting this pathway to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th17 CellsHyperkeratosis, EpidermolyticInflammationHumansMaleFemaleKeratin-1Keratin-10MutationInterleukin-17AdultCytokinesChild

Stichwörter der Autor:innen

Epidermolytic ichthyosisIL-8KeratinTH17 inflammatory responses

Substanzen

Keratin-1KRT1 protein, humanKeratin-10Interleukin-17KRT10 protein, humanCytokines

Autor:innen und Institutionen

  • Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China; Institute of Dermatolog…

Förderung

  • Fundamental Research Funds for the Central Universities
  • Fundamental Research Funds for Central Universities of the Central South University

Zitieren

APA

Tan, Y., Chen, X., Shen, Y., Yang, J., Wang, B., Wang, Y., Zhou, W., Han, Q., Yao, Z., Li, H., & Liang, J. (2025). Exploring TH17-mediated inflammation in epidermolytic ichthyosis: Clinical and mechanistic insight. Clinical Immunology. https://doi.org/10.1016/j.clim.2025.110494

Vancouver

Tan Y, Chen X, Shen Y, Yang J, Wang B, Wang Y, et al. Exploring TH17-mediated inflammation in epidermolytic ichthyosis: Clinical and mechanistic insight. Clinical Immunology. 2025. doi:10.1016/j.clim.2025.110494

BibTeX
@article{Tan2025,
  author = {Tan, Yidong and Chen, Xuanyi and Shen, Yihang and Yang, Jinxiang and Wang, Bing and Wang, Yumeng and Zhou, Weinan and Han, Qiuyi and Yao, Zhirong and Li, Huaguo and Liang, Jianying},
  title = {Exploring TH17-mediated inflammation in epidermolytic ichthyosis: Clinical and mechanistic insight},
  journal = {Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.clim.2025.110494}
}
Kostenlos starten →